Safety and effectiveness of biphasic insulin aspart 30 in people with type 2 diabetes switching from basal-bolus insulin regimens in the A1chieve study-Reference-Cited by-同舟云学术

Safety and effectiveness of biphasic insulin aspart 30 in people with type 2 diabetes switching from basal-bolus insulin regimens in the A1chieve study

Published:2014-07 Issue:2 Volume:8 Page:111-117
ISSN:1751-9918
Container-title:Primary Care Diabetes
language:en
Short-container-title:Primary Care Diabetes

Author:

Dieuzeide Guillermo,Chuang Lee-Ming,Almaghamsi Abdulrahman,Zilov Alexey,Chen Jian-Wen,Lavalle-González Fernando J.

Publisher

Elsevier BV

Subject

Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Internal Medicine,Family Practice

Reference24 articles.

1. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial;Diabetes,1996

2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33);UK Prospective Diabetes Study (UKPDS) Group;Lancet,1998

3. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetes Care,2012

4. Biphasic insulin aspart given thrice daily is as efficacious as a basal-bolus insulin regimen with four daily injections: a randomised open-label parallel group four months comparison in patients with type 2 diabetes;Ligthelm;Experimental and Clinical Endocrinology and Diabetes,2006

5. Insulin treatment for type 2 diabetes: when to start, which to use;Hamaty;Cleveland Clinic Journal of Medicine,2011

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin therapy in type 2 diabetes: Insights into clinical efficacy, patient-reported outcomes, and adherence challenges;World Journal of Diabetes;2024-05-15

2. Transfert d’un schéma basal plus/basal-bolus vers un analogue d’une insuline prémix : rationnel et consensus;Médecine des Maladies Métaboliques;2019-11

3. 15 Years of Experience with Biphasic Insulin Aspart 30 in Type 2 Diabetes;Drugs in R&D;2018-02-21

4. Use of Biphasic Insulin Aspart 30 in Type 2 Diabetes Treatment: Expert Panel Recommendations;The Turkish Journal of Endocrinology and Metabolism;2018

5. Summary of Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017;The Journal of Korean Diabetes;2018